Simbulan-Rosenthal, C.M.; Dougherty, R.; Vakili, S.; Ferraro, A.M.; Kuo, L.-W.; Alobaidi, R.; Aljehane, L.; Gaur, A.; Sykora, P.; Glasgow, E.;
et al. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. Cancers 2019, 11, 1490.
https://doi.org/10.3390/cancers11101490
AMA Style
Simbulan-Rosenthal CM, Dougherty R, Vakili S, Ferraro AM, Kuo L-W, Alobaidi R, Aljehane L, Gaur A, Sykora P, Glasgow E,
et al. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. Cancers. 2019; 11(10):1490.
https://doi.org/10.3390/cancers11101490
Chicago/Turabian Style
Simbulan-Rosenthal, Cynthia M., Ryan Dougherty, Sahar Vakili, Alexandra M. Ferraro, Li-Wei Kuo, Ryyan Alobaidi, Leala Aljehane, Anirudh Gaur, Peter Sykora, Eric Glasgow,
and et al. 2019. "CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis" Cancers 11, no. 10: 1490.
https://doi.org/10.3390/cancers11101490
APA Style
Simbulan-Rosenthal, C. M., Dougherty, R., Vakili, S., Ferraro, A. M., Kuo, L.-W., Alobaidi, R., Aljehane, L., Gaur, A., Sykora, P., Glasgow, E., Agarwal, S., & Rosenthal, D. S.
(2019). CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. Cancers, 11(10), 1490.
https://doi.org/10.3390/cancers11101490